The influence teatment of acupuncture and moxibution gives it to breast cancer postoperation immunity

Study of the recurrence rate in the treatment in use crowd of acupuncture and moxibution and non-in use crowd of breast cancer post-operatively - The recurrence rate in the treatment acupuncture and moxibution of breast cancer post-operatively

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042462

Enrollment

Registered

2020-11-16

Start date

2003-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

After the breast cancer operation under chemoterapy

Interventions

Acupuncture snd moxibution treatment per 2weeks under cemoterapy of breast cancer post-operative Under chemoterapy of breast cancer post-operative not do acupuncture and moxibution terapy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: During postoperation cehmoterapy for breast cancer

Exclusion criteria

Exclusion criteria: Cases in which informed consent could not be obtained

Design outcomes

Primary

Measure	Time frame
10years late brest cancer recurrence rate	—

Secondary

Measure	Time frame
White blood cell and lynphocyte Th1/Th2 CA 15-3 and Treg measure every 3 months	—

Countries

Japan

Contacts

Public Contacttakeo mizushima

mizushima clinic medical office

miz323@poplar.ocn.ne.jp0256-63-5353

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026